News All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen Staff January 26, 2024 Please read the full announcement in PDF Attachment 2024_01_All_Regulatory_Approvals_Obtained Continue Reading Previous Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024Next All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen More Stories Cancer Clinical Trial EHR News Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024 Staff June 8, 2024 Cancer Clinical Trial News Pharmaceutical Seniors Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly Staff June 8, 2024 News Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders Staff June 8, 2024
